Joanna Panecka-Hofman

6PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsChemical and thermal processes in energy and combustionToxicology (incl. clinical toxicology)Cheminformatics and quantitative structure-activity relationshipsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2025
Design of 2-Aminobenzothiazole Derivatives Targeting Trypanosomatid PTR1 by a Multidisciplinary Fragment Hybridization Approach.

Joanna Panecka-Hofman, Pasquale Linciano, Ina Pöhner

|Aug 23, 2023
Structure and dynamics of pteridine reductase 1: the key phenomena relevant to enzyme function and drug design.

Joanna Panecka-Hofman, Ina Poehner

|Feb 04, 2023
An engineered variant of MECR reductase reveals indispensability of long-chain acyl-ACPs for mitochondrial respiration.

M Tanvir Rahman, M Kristian Koski, Joanna Panecka-Hofman

|Sep 08, 2022
Anti-trypanosomatid structure-based drug design - lessons learned from targeting the folate pathway.

Joanna Panecka-Hofman, Ina Poehner, Rebecca C Wade

|Jun 08, 2022
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.

Ina Pöhner, Antonio Quotadamo, Joanna Panecka-Hofman

|May 28, 2022
Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism.

Dorota Kubacka, Mateusz Kozarski, Marek R Baranowski

Pageof 1